XML 29 R5.htm IDEA: XBRL DOCUMENT v2.3.0.15
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands
9 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Cash flows from operating activities  
Net loss$ (78,337)$ (64,563)
Adjustments to reconcile net loss to net cash used in operating activities:  
Depreciation and amortization5,4594,697
Stock-based compensation18,70614,316
Forgiveness of notes receivable1618
Changes in operating assets and liabilities:  
Receivables11375
Prepaid expenses and other current assets1,9831,727
Accounts payable1,44694
Accrued personnel-related expenses, accrued clinical and development expenses, accrued interest on convertible subordinated notes and other current liabilities(679)(1,585)
Deferred rent2,3361,637
Deferred revenue(14,025)(16,100)
Other liabilities, non-current (389)
Net cash used in operating activities(62,982)(60,073)
Cash flows from investing activities  
Purchases of property and equipment(2,723)(286)
Purchases of marketable securities(231,284)(134,058)
Sales of marketable securities8,75010,009
Maturities of marketable securities164,401101,500
Release of restricted cash 417
Additions to notes receivable(140) 
Payments received on notes receivable630140
Net cash used in investing activities(60,366)(22,278)
Cash flows from financing activities  
Payments on note payable and capital lease(166)(148)
Proceeds from issuances of common stock, net22,91798,056
Net cash provided by financing activities22,75197,908
Net increase (decrease) in cash and cash equivalents(100,597)15,557
Cash and cash equivalents at beginning of period163,33347,544
Cash and cash equivalents at end of period$ 62,736$ 63,101